Rama Al Hamed

817 total citations
11 papers, 487 citations indexed

About

Rama Al Hamed is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Rama Al Hamed has authored 11 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Rama Al Hamed's work include Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Rama Al Hamed is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Rama Al Hamed collaborates with scholars based in France, Lebanon and United States. Rama Al Hamed's co-authors include Abdul Hamid Bazarbachi, Mohamad Mohty, Florent Malard, Jean‐Luc Harousseau, Ali Bazarbachi, Razan Mohty, Malvi Savani, Rémy Duléry, Arnon Nagler and Johanna Tischer and has published in prestigious journals such as Blood, Cancer and Leukemia.

In The Last Decade

Rama Al Hamed

10 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rama Al Hamed France 9 308 236 223 71 56 11 487
Sjoerd Hovenga Netherlands 12 242 0.8× 194 0.8× 161 0.7× 65 0.9× 87 1.6× 21 411
Ryan J. Mattison United States 12 273 0.9× 238 1.0× 111 0.5× 44 0.6× 159 2.8× 58 518
Iman Abou Dalle Lebanon 12 261 0.8× 140 0.6× 107 0.5× 51 0.7× 60 1.1× 46 430
Alissa Visram Canada 12 244 0.8× 158 0.7× 198 0.9× 22 0.3× 41 0.7× 57 403
Neil Palmisiano United States 13 162 0.5× 156 0.7× 228 1.0× 128 1.8× 54 1.0× 64 491
Lynn Savoie Canada 11 298 1.0× 238 1.0× 170 0.8× 97 1.4× 144 2.6× 25 523
Rafael Martínez Spain 8 252 0.8× 168 0.7× 173 0.8× 122 1.7× 123 2.2× 16 428
Satyajit Kosuri United States 12 247 0.8× 128 0.5× 150 0.7× 35 0.5× 51 0.9× 47 420
Raya Mawad United States 13 264 0.9× 127 0.5× 214 1.0× 52 0.7× 39 0.7× 38 459
Loredana Santo United States 9 456 1.5× 383 1.6× 326 1.5× 45 0.6× 59 1.1× 23 633

Countries citing papers authored by Rama Al Hamed

Since Specialization
Citations

This map shows the geographic impact of Rama Al Hamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rama Al Hamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rama Al Hamed more than expected).

Fields of papers citing papers by Rama Al Hamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rama Al Hamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rama Al Hamed. The network helps show where Rama Al Hamed may publish in the future.

Co-authorship network of co-authors of Rama Al Hamed

This figure shows the co-authorship network connecting the top 25 collaborators of Rama Al Hamed. A scholar is included among the top collaborators of Rama Al Hamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rama Al Hamed. Rama Al Hamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Bazarbachi, Abdul Hamid, Rama Al Hamed, Florent Malard, et al.. (2022). Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update. Blood Cancer Journal. 12(3). 47–47. 22 indexed citations
3.
Mohty, Razan, Rama Al Hamed, Ali Bazarbachi, et al.. (2022). Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease. Journal of Hematology & Oncology. 15(1). 124–124. 9 indexed citations
5.
Mohty, Razan, Rémy Duléry, Abdul Hamid Bazarbachi, et al.. (2021). Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies. Blood Cancer Journal. 11(7). 126–126. 27 indexed citations
6.
Hamed, Rama Al, Abdul Hamid Bazarbachi, Ali Bazarbachi, et al.. (2021). Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal. 11(5). 97–97. 53 indexed citations
7.
Bazarbachi, Abdul Hamid, Abdul Hamid Bazarbachi, Rama Al Hamed, et al.. (2019). Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant. Therapeutic Advances in Hematology. 10. 153174442–153174442. 20 indexed citations
8.
Bazarbachi, Abdul Hamid, Rama Al Hamed, Myriam Labopin, et al.. (2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation. 55(3). 595–602. 18 indexed citations
10.
Bazarbachi, Abdul Hamid, Rama Al Hamed, Florent Malard, Jean‐Luc Harousseau, & Mohamad Mohty. (2019). Relapsed refractory multiple myeloma: a comprehensive overview. Leukemia. 33(10). 2343–2357. 112 indexed citations
11.
Hamed, Rama Al, Abdul Hamid Bazarbachi, Florent Malard, Jean‐Luc Harousseau, & Mohamad Mohty. (2019). Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer Journal. 9(4). 44–44. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026